The Evolving Role of Coronary Artery Imaging in Assessing Cardiovascular Risk from Lipoprotein(a).

Authors

Michael T Savides, Harpreet S Bhatia, Inna Kuznetsova, Michael J Wilkinson

Published in

Current atherosclerosis reports. Volume 28. Issue 1. Jul 10, 2026. Epub Jul 10, 2026.

Abstract

Summarize current literature on the use of coronary artery imaging modalities in examining the atherosclerotic and arterial inflammatory manifestations of elevated lipoprotein(a) [Lp(a)]. Evaluate the evolving role of coronary imaging in risk stratification and treatment decisions.
While Lp(a) and calcium scoring (CAC) are independently associated with cardiovascular risk, Lp(a) is associated with CAC incidence and progression. Lp(a) is associated with greater plaque prevalence, multivessel disease, and high-risk morphologies, while also being linked to accelerated progression of mixed and lipid-rich plaque by coronary CT angiography. Intravascular imaging modalities further show associations between Lp(a) and thin-cap fibroatheroma, lipid-rich plaque, percent atheroma volume, and plaque progression. Lp(a) is associated with non-calcified or mixed coronary plaque morphology and progression, as well as increased risk of high-risk plaque features. While additional research is needed, current literature suggests that coronary imaging may be an important tool in cardiovascular risk stratification for individuals with elevated Lp(a).

PMID:
42429866
Bibliographic data and abstract were imported from PubMed on 10 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.